Jonathan Sessler (born 20 May 1956 in Urbana, Illinois) is a professor of chemistry at The University of Texas at Austin. He is notable for his pioneering work on expanded porphyrins and their applications to biology and medicine. He is a co-founder of Pharmacyclics, Inc., a company that works with expanded porphyrins, and Anionics, Inc., which develops anion recognition chemistry. Pharmacyclics was sold to AbbVie for $21 billion in 2015.[2][3]
Jonathan L. Sessler | |
|---|---|
 Jonathan L. Sessler | |
| Born | 20 May 1956 |
| Citizenship | American |
| Education | MSc at University of California, Berkeley PhD at Stanford University Postdoc at Louis Pasteur University |
| Alma mater | University of California Stanford University |
| Known for |
|
| Scientific career | |
| Institutions | University of Texas at Austin |
| Thesis | (1982) |
| Doctoral advisor | James P. Collman[1] |
History and career
editSessler received his Bachelor of Science in Chemistry in 1977 from the University of California, Berkeley and his Ph.D. in chemistry in 1982 from Stanford University. He continued as a post-doctoral fellow at L'Université Louis Pasteur, and worked in Kyoto, Japan before becoming an assistant professor of chemistry at The University of Texas at Austin in 1984.
He is a three-time Hodgkin's Lymphoma cancer survivor. He was treated for cancer at Stanford University Medical Center during work on his Ph.D. Discussions with his colleagues regarding possible treatments eventually led to the discovery of so-called "texaphyrin" molecules, named as such due a semblance to the shape of the five-pointed star in the State flag of Texas.[1],10-Gallon Molecule Stomps Tumors In 1996, Sessler described possible uses of these compounds in medicine in the Proceedings of the National Academy of Sciences journal. He formed a company, Pharamcyclics, Inc., with Dr. Richard A. Miller whom treated him for his cancer. His company,which went public in 1995, licensed the technology behind "texaphyrins" from the university to develop commercial and medical uses for the molecules. The company was later acquired by Bob Duggan in the year 2008 as he became the largest shareholder of the company.
Sessler has written extensively, authoring or co-authoring over 600 publications. In addition, he has co-authored two books and edited another two.[5] He holds more than 70 U.S. patents. Dr. Sessler has received many awards and much recognition, as a Sloan Fellow (1999), Fellow of the AAAS (1999), Dreyfus Teacher-Scholar (1999), ACS Cope Scholar (1999), recipient of the JSPS and Alexander von Humboldt Senior Fellowships (1999), and winner of the Izatt-Christensen Award (1999).
Sessler has participated in hosting chemistry circuses on the UT campus.University Events | What Starts Here Changes the World, UT DISCOVERY MAGAZINE v15n4 Science Fun Day photo These circuses are held for different grade levels from elementary to college, and aim to expose students to "fun" aspects of chemistry. Sessler has also lectured on how the disease Porphyria, caused by a deficiency in porphyrins, may be related to the origin of myths about vampires and werewolves.
In 2021, he was elected member of the U. S. National Academy of Sciences.[6]
References
edit- ^ "Jonathan L Sessler". utexas.edu. UT Experts.
- ^ "AbbVie Completes Acquisition of Pharmacyclics | AbbVie Newsroom". news.abbvie.com. Archived from the original on 2018-01-29. Retrieved 2018-07-11.
- ^ "AbbVie buys cancer drugmaker Pharmacyclics in $21B deal". USA TODAY. Retrieved 2018-07-11.
- ^ Preihs, Christian; Arambula, Jonathan F.; Magda, Darren; Jeong, Heeyeong; Yoo, Dongwon; Cheon, Jinwoo; Siddik, Zahid H.; Sessler, Jonathan L. (April 4, 2013). "Recent Developments in Texaphyrin Chemistry and Drug Discovery". Inorg. Chem. 52 (21): 12184–12192. doi:10.1021/ic400226g. PMC 3963820. PMID 23557113.
- ^ "Archived copy" (PDF). Archived from the original (PDF) on 2019-05-31. Retrieved 2019-05-31.
{{cite web}}: CS1 maint: archived copy as title (link) - ^ "News from the National Academy of Sciences". April 26, 2021. Retrieved July 5, 2021.
Newly elected members and their affiliations at the time of election are: … Sessler, Jonathan L.; R.P. Doherty Jr.-Welch Regents Chair in Chemistry and professor, department of chemistry, University of Texas, Austin
, entry in member directory:"Member Directory". National Academy of Sciences. Retrieved July 5, 2021.
External links
edit- Jonathan L. Sessler — Department of Chemistry & Biochemistry, The University of Texas at Austin. Accessed 14 March 2006.
- Company History & Overview Archived 2006-03-21 at the Wayback Machine — Phaymacyclics.com. Accessed 14 March 2006.
- Jonathan Sessler Distinguished Lecture Series Acknowledgement — Stanford University. Accessed 14 March 2006. (password-protected)
- "Interview: Discovering the Texas molecule" - - Jonathan Sessler talks to The Royal Society of Chemistry about what motivated him to discover texaphyrin and about the aims of the companies he co-founded [dead link]